Oragenics, Inc. Submits Investigator’s Brochure for Phase II Clinical Trial of ONP-002 in Mild Traumatic Brain Injury (mTBI)
Oragenics, Inc. (NYSE American: OGEN), a biotechnology company advancing innovative treatments for concussion and ...
Nasdaq19d
Oragenics, Inc. Submits Investigator's Brochure for Phase II Clinical Trial of ONP-002 in Australia for Mild Traumatic Brain Injury
no FDA-approved drug therapies currently exist, leaving a significant unmet medical need. “The submission of our Investigator’s Brochure application marks a critical step forward in advancing ...
Yahoo Finance25d
Psychedelic: GH Research, Compass Pathways report earnings results
additional device design verification information and updates to our investigator brochure, to resolve the hold. We have recently announced the completion of all FDA requests to address IND hold.
Moderna (MRNA) Presents at Barclays 27th Annual Global Healthcare Conference (Transcript)
Barclays 27th Annual Global Healthcare Conference March 11, 2025 1:30 PM ETCompany ParticipantsRose Loughlin - EVP of ...
Bogus promises of work on Coronation Street and Hollyoaks - how ex-actor lived life of luxury funded by £13.6m sham model agency scam
Philip Foster, who once appeared on Brookside, has been handed a jail sentence in his absence as he remains in Spain. His ...
Investing14d
Moderna at Barclays Conference: Strategic Focus on Oncology and Vaccines
So this is consent forms, investigator brochures for that trial. But in doing that, we also alerted the FDA that we were taking this action on ourselves and that’s when we were officially put on hold ...